Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort
DeMichele A, Aplenc R, Botbyl J, et al: Drug-metabolizing enzyme polymorphisms predict clinical outcome in a node-positive breast cancer cohort. J Clin Oncol 23:5552-5559, 2005
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy
Moore HC, Mick R, Solin LJ, et al: Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: Impact on the delivery of local-regional radiation therapy. Ann Oncol 10:929-936, 1999
Glutathione S-transferase polymorphisms in children with myeloid leukemia: A Children's Cancer Group study
Davies SM, Robison LL, Buckley JD, et al: Glutathione S-transferase polymorphisms in children with myeloid leukemia: A Children's Cancer Group study. Cancer Epidemiol Biomarkers Prev 9:563-566, 2000
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
Kuehl P, Zhang J, Lin Y, et al: Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 27:383-391, 2001
Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion
Seidegard J, Vorachek WR, Pero RW, et al: Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion. Proc Natl Acad Sci U S A 85:7293-7297, 1988